KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Asset Writedowns and Impairment (2016 - 2026)

Medtronic's Asset Writedowns and Impairment history spans 13 years, with the latest figure at $36.0 million for Q1 2026.

  • For Q1 2026, Asset Writedowns and Impairment fell 29.41% year-over-year to $36.0 million; the TTM value through Jan 2026 reached $6.0 million, down 98.52%, while the annual FY2024 figure was $371.0 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 was $36.0 million at Medtronic, down from $38.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $309.0 million in Q2 2024 and bottomed at -$466.0 million in Q1 2022.
  • The 5-year median for Asset Writedowns and Impairment is $21.0 million (2023), against an average of $941176.5.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 700.0% in 2023 before it soared 672.22% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $26.0 million in 2022, then crashed by 38.46% to $16.0 million in 2023, then soared by 68.75% to $27.0 million in 2024, then soared by 40.74% to $38.0 million in 2025, then dropped by 5.26% to $36.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Asset Writedowns and Impairment are $36.0 million (Q1 2026), $38.0 million (Q4 2025), and $28.0 million (Q3 2025).